DKG/DGS requirement | |||||||||
---|---|---|---|---|---|---|---|---|---|
QI No. | Quality indicator (QI) | Year of introduction | 2003 | 2004 | 2005 | 2006 | 2007 | 1st year | 3rd year |
1 | Preoperative histological confirmation of diagnosis | 2003 | 58% | 71% | 78% | 84% | 88% | 90%a | 90%a |
2 | Appropriate axillary dissection | 2003 | 85% | 85% | 80% | 83% | 88% | 85% | 95% |
[ex-3] b | Complete tumour staging data | 2003 | 85% | 96% | 98% | 95% | > 95% | > 95% | |
3 | Data on safety distance between tumour and resection margin | 2007 | 91% | 100% | 100% | ||||
[ex-4] b | HER-2/neu assessment | 2005 | 94% | 98% | > 95% | > 95% | |||
4 | Specimen radiography | 2007 | 83% | > 95% | > 95% | ||||
5 | Hormone receptor assessment | 2003 | 92% | 96% | 96% | 97% | 98% | 100% | 100% |
6 | Appropriate endocrine therapy in hormone receptor-positive patients | 2003 | 27% | 82% | 92% | 94% | 93% | 70% | 95% |
7.1 | Appropriate adjuvant and neoadjuvant chemotherapy | 2003 | |||||||
7.1a | during the current analysis period; age ≤ 70 years | 2005 | 65% | 75% | 81% | 70% | 80% | ||
7.1b | during the current analysis period; no age limit | 2003 | 32% | 45% | 55% | 63% | 80% | -- | -- |
7.2 | Use of appropriate standard regimens in chemotherapy | 2005 | |||||||
7.2a | during the current analysis period; age ≤ 70 years | 2006 | 65% | 72% | -- | -- | |||
7.2b | during the current analysis period; no age limit | 2005 | 57% | 60% | 69% | -- | -- | ||
8 | Percentage of patients in clinical trials | 2005 | 8% | 7% | 7% | 10% | 20% | ||
9 | Appropriate radiotherapy after breast-conserving therapy | 2003 | 20% | 46% | 60% | 70% | 79% | 100%c | 100%c |
10 | Appropriate radiotherapy after mastectomy | 2003 | 8% | 26% | 35% | 47% | 65% | 100%c | 100%c |
11 | Indication for breast-conserving therapy | 2003 | |||||||
11a | at any tumour stage | 2003 | 64% | 66% | 64% | 68% | 70% | -- | -- |
11b | at T1 | 2005 | 79% | 83% | 85% | 50% | 70% | ||
11c | at T2 | 2006 | 60% | 63% | -- | -- | |||
11d | at T3 | 2006 | 15% | 13% | -- | -- | |||
11e | at T4 | 2006 | 15% | 12% | -- | -- |